UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Drug hypersensitivity in drug-resistant tuberculosis

The World Allergy Organization journal, 2023-05, Vol.16 (5), p.100778-100778, Article 100778

2023

Volltextzugriff (PDF)

Hypersensitivity Reaction and Rapid Drug Desensitization with Chemotherapeutics: A Tertiary Reference Center Experiences

International archives of allergy and immunology, 2023-09, Vol.184 (9), p.849-855

2023

Volltextzugriff (PDF)

Results of patch testing to the European Baseline Series in adult patients in Turkey: a five-year experience at a tertiary reference center

Alergologia Polska - Polish Journal of Allergology, 2024, Vol.11 (1), p.10-16

2024

Volltextzugriff (PDF)

Management of type 1 immediate hypersensitivity reactions to antituberculosis drug: succesful desensitization

Allergy, asthma, and clinical immunology, 2022-11, Vol.18 (1), p.1-97, Article 97

2022

Volltextzugriff (PDF)

Evaluation of multidrug resistance-1 gene C>T polymorphism frequency in patients with asthma

Clinics (São Paulo, Brazil), 2015-10, Vol.70 (10), p.670-674

2015

Volltextzugriff (PDF)

Anaphylaxis in a country where Asia and Europe meet: Evaluation according to World Allergy Organization (WAO) and European Academy of Allergy and Clinical Immunology (EAACI) diagnostic criteria

The World Allergy Organization journal, 2024-09, Vol.17 (9), p.100962, Article 100962

2024

Volltextzugriff (PDF)

Tuberculosis treatment-related lichenoid drug eruptions

International journal of mycobacteriology, 2022-10, Vol.11 (4), p.469-471

2022

Volltextzugriff (PDF)

Treatment and management of hypersensitivity reactions developed against anti-tuberculosis drug

International journal of mycobacteriology, 2022-07, Vol.11 (3), p.309-317

2022

Volltextzugriff (PDF)

IGFBP-4: A promising biomarker for lung cancer

Journal of medical biochemistry, 2021-01, Vol.40 (3), p.237-244

2021

Volltextzugriff (PDF)

Economic burden of short-acting beta-2 agonist (SABA) overuse among asthma patients in Türkiye: a cost analysis with respect to the updated GINA treatment recommendations

BMC pulmonary medicine, 2024-10, Vol.24 (1), p.524-10, Article 524

2024

Volltextzugriff (PDF)

Effectiveness of mepolizumab in patients with severe eosinophilic asthma: In a real life study

Tuberkuloz ve toraks, 2023-06, Vol.71 (2), p.148-155

2023

Volltextzugriff (PDF)

Relationship Between Pregnancy-Associated Plasma Protein-A and Lung Cancer

The American journal of the medical sciences, 2009-04, Vol.337 (4), p.241-244

2009

Volltextzugriff (PDF)

Should patients with risk factors be tested for hypersensitivity to contrast media: a prospective study

Radiologia medica, 2016-08, Vol.121 (8), p.660-666

2016

Volltextzugriff (PDF)

Short-acting β 2 -agonist prescription patterns in patients with asthma in Turkey: results from SABINA III

BMC pulmonary medicine, 2022-06, Vol.22 (1), p.216

2022

Volltextzugriff (PDF)

Effect of symptom-to-treatment interval on prognosis in lung cancer

Tumori, 2007-01, Vol.93 (1), p.61-67

2007

Volltextzugriff (PDF)

Allergic Bronchopulmonary Aspergillosis Treated with Mepolizumab and Omalizumab: Switching Biological Agents

Astım allerji immünoloji, 2023-01, p.113-119

2023

Volltextzugriff (PDF)

Delayed drug hypersensitivity to anti-tuberculosis drug: a new desensitization scheme

Postȩpy dermatologii i alergologii, 2024-08, Vol.41 (4), p.400-407

2024

Volltextzugriff (PDF)

Pregnancy-associated plasma protein-A and asthma

Advances in therapy, 2007-03, Vol.24 (2), p.362-367

2007

Volltextzugriff (PDF)

Psychiatric comorbidity and quality of life in patients with drug hypersensitivity

Allergy and asthma proceedings, 2022-05, Vol.43 (3), p.234-242

2022

Volltextzugriff (PDF)

Pregnancy-associated plasma protein-A (PAPP-A) levels in patients with severe allergic asthma are reduced by omalizumab

The Journal of asthma, 2018-10, Vol.55 (10), p.1116-1121

2018

Volltextzugriff (PDF)

The significance of eosinophil and eosinophil lymphocyte ratio (ELR) in predicting response to omalizumab treatment in patients with severe allergic asthma

Tüberküloz ve toraks, 2021-03, Vol.69 (1), p.39-48

2021

Volltextzugriff (PDF)

Congenital lobar emphysema: is surgery routinely necessary?

African journal of paediatric surgery, 2010-01, Vol.7 (1), p.36-37

2010

Volltextzugriff (PDF)

Comparision Between Treatment Persistence With Omalizumab in Severe Allergic Asthma and Subcutaneous Immunotherapy in Severe Allergic Rhinitis

Chest, 2013, Vol.144 (4), p.77A-77B

2013

Volltextzugriff (PDF)

Epiglottic Tuberculosis in a Patient Treated with Steroids for Addison’s Disease

The Tohoku Journal of Experimental Medicine, 2003, Vol.201(2), pp.119-125

2003

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(71)
Tagungsberichte
(1)

Sprache

Englisch
(67)
Türkisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Drug hypersensitivity in drug-resistant tuberculosis

Hypersensitivity Reaction and Rapid Drug Desensitization with Chemotherapeutics: A Tertiary Reference Center Experiences

Results of patch testing to the European Baseline Series in adult patients in Turkey: a five-year experience at a tertiary reference center

Management of type 1 immediate hypersensitivity reactions to antituberculosis drug: succesful desensitization

Evaluation of multidrug resistance-1 gene C>T polymorphism frequency in patients with asthma

Anaphylaxis in a country where Asia and Europe meet: Evaluation according to World Allergy Organization (WAO) and European Academy of Allergy and Clinical Immunology (EAACI) diagnostic criteria

Tuberculosis treatment-related lichenoid drug eruptions

Treatment and management of hypersensitivity reactions developed against anti-tuberculosis drug

IGFBP-4: A promising biomarker for lung cancer

Economic burden of short-acting beta-2 agonist (SABA) overuse among asthma patients in Türkiye: a cost analysis with respect to the updated GINA treatment recommendations

Effectiveness of mepolizumab in patients with severe eosinophilic asthma: In a real life study

Relationship Between Pregnancy-Associated Plasma Protein-A and Lung Cancer

Short-acting β2-agonist prescription patterns in patients with asthma in Turkey: results from SABINA III

Should patients with risk factors be tested for hypersensitivity to contrast media: a prospective study

Short-acting β 2 -agonist prescription patterns in patients with asthma in Turkey: results from SABINA III

Effect of symptom-to-treatment interval on prognosis in lung cancer

Allergic Bronchopulmonary Aspergillosis Treated with Mepolizumab and Omalizumab: Switching Biological Agents

Delayed drug hypersensitivity to anti-tuberculosis drug: a new desensitization scheme

Pregnancy-associated plasma protein-A and asthma

Psychiatric comorbidity and quality of life in patients with drug hypersensitivity

Pregnancy-associated plasma protein-A (PAPP-A) levels in patients with severe allergic asthma are reduced by omalizumab

The significance of eosinophil and eosinophil lymphocyte ratio (ELR) in predicting response to omalizumab treatment in patients with severe allergic asthma

Congenital lobar emphysema: is surgery routinely necessary?

Comparision Between Treatment Persistence With Omalizumab in Severe Allergic Asthma and Subcutaneous Immunotherapy in Severe Allergic Rhinitis

Epiglottic Tuberculosis in a Patient Treated with Steroids for Addison’s Disease

Suchergebnisse filtern